Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
World Health Organisation, 1992. Expanded program on immunization. Global Advisory Group–Part 1. Wkly Epidemiol Rec 67 :11–15.
-
2
Hipgrave DB, Nyugen TV, Vu NH, Hoang TL, Do TD, Tran NT, Jolley D, Maynard JE, Biggs BA, 2003. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am J Trop Med Hyg 69 :88–94.
-
3
Tran VB, Buu M, Nguyen TM, Morris GE, 1993. Hepatitis B in Ho Chi Minh City, Viet Nam. Trans R Soc Trop Med Hyg 87 :262.
-
4
Nakata S, Song P, Duc DD, Nguyen XQ, Murata K, Tsuda F, Okamoto H, 1994. Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. J Gastroenterol Hepatol 9 :416–419.
-
5
Katelaris PH, Robertson G, Bradbury R, Tippett G, Hoa DQ, Ngu MC, 1995. Seroprevalence of hepatitis viruses in children in rural Viet Nam. Trans R Soc Trop Med Hyg 89 :487.
-
6
Vietnam Demographic and Health Survey, 2002. Calverton, MD: Committee for Population, Family and Children (Vietnam) and ORC Macro., 2003.
-
7
Anonymous, 1991. Hepatitis B vaccine delivery outside the cold chain: the Long An County, China example. Global Perspectives Hepatitis 2 :3–4.
-
8
Sutanto A, Suarnawa IM, Nelson CM, Stewart T, Soewarso TI, 1999. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. Bull World Health Organ 77 :119–126.
-
9
Otto BF, Suarnawa IM, Stewart T, Nelson C, Ruff TA, Widjaya A, Maynard JE, 1999. At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain. Vaccine 18 :498–502.
-
10
Diminsky D, Moav N, Gorecki M, Barenholz Y, 2000. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 18 :3–17.
-
11
Just M, Berger R, 1988. Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine. Vaccine 6 :399–400.
-
12
van Damme P, Cramm M, Safary A, Vandepapeliere P, Meheus A, 1992. Heat stability of a recombinant DNA hepatitis B vaccine. Vaccine 10 :366–367.
-
13
Galazka A, Milstien J, Zaffram M, 1998. Thermostability of Vaccines. Global Programme for Vaccines and Immunization. Geneva: World Health Organization. WHO/GPV/98.07.
-
14
Hadler SC, de Monzon MA, Lugo DR, Perez M, 1989. Effect of timing of hepatitis B vaccine doses on response to Vaccine in Yucpa Indians. Vaccine 7 :106–110.
-
15
West DJ, 1993. Scope and design of hepatitis B vaccine clinical trials. Ellis RW, ed. Hepatitis B Vaccines in Clinical Practice. New York: Dekker Inc., 159–178.
-
16
Moulia-Pelat JP, Spiegel A, Martin PM, Cardines R, Boutin JP, Roux JF, Excler JL, Saliou P, 1994. A 5-year immunization field trial against hepatitis B using a Chinese hamster ovary cell recombinant vaccine in French Polynesian newborns: results at 3 years. Vaccine 12 :499–502.
-
17
Honorati MC, Palareti A, Donzani D, Busachi CA, Rizzoli R, Facchini A, 1999. A mathematical model predicting anti-HBs decay after vaccination against hepatitis B. Clin Exp Immunol 116 :121–126.
-
18
Mast E, Mahoney F, Kane M, Margolis H, 2004. Hepatitis B vaccine. Plotkin S, Orenstein W, Offit P, eds. Vaccines. Fourth edition. Philadelphia: W. B. Saunders Co., 299–337.
-
19
Lo KJ, Tsai YT, Lee SD, Wu TC, Wang JY, Chen GH, Yeh CL, Chiang BN, Yeh SH, Goudeau A, Coursaget P, Tong MJ, 1985. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis 152 :817–822.
-
20
Andre FE, Zuckerman AJ, 1994. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 44 :144–151.
-
21
Department of Vaccines and Biologicals, 2002. Getting Started with Vaccine Vial Monitors. Geneva: World Health Organization. WHO/V&B/02.35.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 20 | 20 | 7 |
| Full Text Views | 237 | 78 | 1 |
| PDF Downloads | 61 | 16 | 2 |
IMMUNOGENICITY OF A LOCALLY PRODUCED HEPATITIS B VACCINE WITH THE BIRTH DOSE STORED OUTSIDE THE COLD CHAIN IN RURAL VIETNAM
DAVID B. HIPGRAVE
DAVID B. HIPGRAVE
International Health Unit, Burnet Institute, Alfred Medical Research and Education Precinct, Prahran, Victoria, Australia; Department of Medicine (Royal Melbourne Hospital/Western Hospital), University of Melbourne, Royal Melbourne Hospital, Parkville, Australia; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam; Program for Appropriate Technology in Health, Hanoi, Vietnam
Search for other papers by DAVID B. HIPGRAVE in
Current site
Google Scholar
PubMed
Search for other papers by DAVID B. HIPGRAVE in
Current site
Google Scholar
PubMed
TRUNG NAM TRAN
TRUNG NAM TRAN
International Health Unit, Burnet Institute, Alfred Medical Research and Education Precinct, Prahran, Victoria, Australia; Department of Medicine (Royal Melbourne Hospital/Western Hospital), University of Melbourne, Royal Melbourne Hospital, Parkville, Australia; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam; Program for Appropriate Technology in Health, Hanoi, Vietnam
Search for other papers by TRUNG NAM TRAN in
Current site
Google Scholar
PubMed
Search for other papers by TRUNG NAM TRAN in
Current site
Google Scholar
PubMed
VU MINH HUONG
VU MINH HUONG
International Health Unit, Burnet Institute, Alfred Medical Research and Education Precinct, Prahran, Victoria, Australia; Department of Medicine (Royal Melbourne Hospital/Western Hospital), University of Melbourne, Royal Melbourne Hospital, Parkville, Australia; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam; Program for Appropriate Technology in Health, Hanoi, Vietnam
Search for other papers by VU MINH HUONG in
Current site
Google Scholar
PubMed
Search for other papers by VU MINH HUONG in
Current site
Google Scholar
PubMed
DO TUAN DAT
DO TUAN DAT
International Health Unit, Burnet Institute, Alfred Medical Research and Education Precinct, Prahran, Victoria, Australia; Department of Medicine (Royal Melbourne Hospital/Western Hospital), University of Melbourne, Royal Melbourne Hospital, Parkville, Australia; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam; Program for Appropriate Technology in Health, Hanoi, Vietnam
Search for other papers by DO TUAN DAT in
Current site
Google Scholar
PubMed
Search for other papers by DO TUAN DAT in
Current site
Google Scholar
PubMed
NGUYEN TUYET NGA
NGUYEN TUYET NGA
International Health Unit, Burnet Institute, Alfred Medical Research and Education Precinct, Prahran, Victoria, Australia; Department of Medicine (Royal Melbourne Hospital/Western Hospital), University of Melbourne, Royal Melbourne Hospital, Parkville, Australia; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam; Program for Appropriate Technology in Health, Hanoi, Vietnam
Search for other papers by NGUYEN TUYET NGA in
Current site
Google Scholar
PubMed
Search for other papers by NGUYEN TUYET NGA in
Current site
Google Scholar
PubMed
HOANG THUY LONG
HOANG THUY LONG
International Health Unit, Burnet Institute, Alfred Medical Research and Education Precinct, Prahran, Victoria, Australia; Department of Medicine (Royal Melbourne Hospital/Western Hospital), University of Melbourne, Royal Melbourne Hospital, Parkville, Australia; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam; Program for Appropriate Technology in Health, Hanoi, Vietnam
Search for other papers by HOANG THUY LONG in
Current site
Google Scholar
PubMed
Search for other papers by HOANG THUY LONG in
Current site
Google Scholar
PubMed
NGUYEN THU VAN
NGUYEN THU VAN
International Health Unit, Burnet Institute, Alfred Medical Research and Education Precinct, Prahran, Victoria, Australia; Department of Medicine (Royal Melbourne Hospital/Western Hospital), University of Melbourne, Royal Melbourne Hospital, Parkville, Australia; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam; Program for Appropriate Technology in Health, Hanoi, Vietnam
Search for other papers by NGUYEN THU VAN in
Current site
Google Scholar
PubMed
Search for other papers by NGUYEN THU VAN in
Current site
Google Scholar
PubMed
JAMES E. MAYNARD
JAMES E. MAYNARD
International Health Unit, Burnet Institute, Alfred Medical Research and Education Precinct, Prahran, Victoria, Australia; Department of Medicine (Royal Melbourne Hospital/Western Hospital), University of Melbourne, Royal Melbourne Hospital, Parkville, Australia; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam; Program for Appropriate Technology in Health, Hanoi, Vietnam
Search for other papers by JAMES E. MAYNARD in
Current site
Google Scholar
PubMed
Search for other papers by JAMES E. MAYNARD in
Current site
Google Scholar
PubMed
BEVERLEY-ANN BIGGS
BEVERLEY-ANN BIGGS
International Health Unit, Burnet Institute, Alfred Medical Research and Education Precinct, Prahran, Victoria, Australia; Department of Medicine (Royal Melbourne Hospital/Western Hospital), University of Melbourne, Royal Melbourne Hospital, Parkville, Australia; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam; Program for Appropriate Technology in Health, Hanoi, Vietnam
Search for other papers by BEVERLEY-ANN BIGGS in
Current site
Google Scholar
PubMed
Search for other papers by BEVERLEY-ANN BIGGS in
Current site
Google Scholar
PubMed
The heat stability of hepatitis B vaccine (HepB vaccine) should enable its storage outside the cold chain (OCC), increasing access to the birth dose in areas lacking refrigeration. We compared the immunogenicity of a locally produced vaccine among infants who received three doses stored within the cold chain (n = 358) or for whom the first dose was stored OCC for up to one month (n = 748). Serum was collected from these infants at age 9–18 months. The vaccine was protective in 80.3% of all infants. There were no differences in the prevalence of a protective level of antibody or antibody titer among groups of infants according to storage strategy. Differences in antibody titer between certain groups of infants could be explained by different vaccination schedules. Where birth dose coverage will be improved, HepB vaccine can be taken OCC for up to one month without affecting its immunogenicity.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
World Health Organisation, 1992. Expanded program on immunization. Global Advisory Group–Part 1. Wkly Epidemiol Rec 67 :11–15.
-
2
Hipgrave DB, Nyugen TV, Vu NH, Hoang TL, Do TD, Tran NT, Jolley D, Maynard JE, Biggs BA, 2003. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am J Trop Med Hyg 69 :88–94.
-
3
Tran VB, Buu M, Nguyen TM, Morris GE, 1993. Hepatitis B in Ho Chi Minh City, Viet Nam. Trans R Soc Trop Med Hyg 87 :262.
-
4
Nakata S, Song P, Duc DD, Nguyen XQ, Murata K, Tsuda F, Okamoto H, 1994. Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. J Gastroenterol Hepatol 9 :416–419.
-
5
Katelaris PH, Robertson G, Bradbury R, Tippett G, Hoa DQ, Ngu MC, 1995. Seroprevalence of hepatitis viruses in children in rural Viet Nam. Trans R Soc Trop Med Hyg 89 :487.
-
6
Vietnam Demographic and Health Survey, 2002. Calverton, MD: Committee for Population, Family and Children (Vietnam) and ORC Macro., 2003.
-
7
Anonymous, 1991. Hepatitis B vaccine delivery outside the cold chain: the Long An County, China example. Global Perspectives Hepatitis 2 :3–4.
-
8
Sutanto A, Suarnawa IM, Nelson CM, Stewart T, Soewarso TI, 1999. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. Bull World Health Organ 77 :119–126.
-
9
Otto BF, Suarnawa IM, Stewart T, Nelson C, Ruff TA, Widjaya A, Maynard JE, 1999. At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain. Vaccine 18 :498–502.
-
10
Diminsky D, Moav N, Gorecki M, Barenholz Y, 2000. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 18 :3–17.
-
11
Just M, Berger R, 1988. Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine. Vaccine 6 :399–400.
-
12
van Damme P, Cramm M, Safary A, Vandepapeliere P, Meheus A, 1992. Heat stability of a recombinant DNA hepatitis B vaccine. Vaccine 10 :366–367.
-
13
Galazka A, Milstien J, Zaffram M, 1998. Thermostability of Vaccines. Global Programme for Vaccines and Immunization. Geneva: World Health Organization. WHO/GPV/98.07.
-
14
Hadler SC, de Monzon MA, Lugo DR, Perez M, 1989. Effect of timing of hepatitis B vaccine doses on response to Vaccine in Yucpa Indians. Vaccine 7 :106–110.
-
15
West DJ, 1993. Scope and design of hepatitis B vaccine clinical trials. Ellis RW, ed. Hepatitis B Vaccines in Clinical Practice. New York: Dekker Inc., 159–178.
-
16
Moulia-Pelat JP, Spiegel A, Martin PM, Cardines R, Boutin JP, Roux JF, Excler JL, Saliou P, 1994. A 5-year immunization field trial against hepatitis B using a Chinese hamster ovary cell recombinant vaccine in French Polynesian newborns: results at 3 years. Vaccine 12 :499–502.
-
17
Honorati MC, Palareti A, Donzani D, Busachi CA, Rizzoli R, Facchini A, 1999. A mathematical model predicting anti-HBs decay after vaccination against hepatitis B. Clin Exp Immunol 116 :121–126.
-
18
Mast E, Mahoney F, Kane M, Margolis H, 2004. Hepatitis B vaccine. Plotkin S, Orenstein W, Offit P, eds. Vaccines. Fourth edition. Philadelphia: W. B. Saunders Co., 299–337.
-
19
Lo KJ, Tsai YT, Lee SD, Wu TC, Wang JY, Chen GH, Yeh CL, Chiang BN, Yeh SH, Goudeau A, Coursaget P, Tong MJ, 1985. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis 152 :817–822.
-
20
Andre FE, Zuckerman AJ, 1994. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 44 :144–151.
-
21
Department of Vaccines and Biologicals, 2002. Getting Started with Vaccine Vial Monitors. Geneva: World Health Organization. WHO/V&B/02.35.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 20 | 20 | 7 |
| Full Text Views | 237 | 78 | 1 |
| PDF Downloads | 61 | 16 | 2 |